Skip to content

Abbott ABT Other Working Capital

Other Working Capital at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
-$48M-226%
Haemonetics logo
HaemoneticsHAE
$5.98M+221%
Artivion logo
ArtivionAORT
$537K+119%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$314K-103%
Boston Scientific logo
Boston ScientificBSX
$27M+486%
DexCom logo
DexComDXCM
$0-100%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.1%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$158.05B-32.0%
Enterprise value$185.3B-22.5%
P/E25.2×+8.5×
P/S3.5×-1.9×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp
FCF margin16.3%+0.6pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Abbott in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's other working capital?
Abbott (ABT) reported other working capital of $420M in Q1 2026.
How has Abbott's other working capital changed year-over-year?
Abbott's other working capital decreased by 3.7% year-over-year, from $436M to $420M.
What does other working capital mean?
Net change in working capital items not separately classified — a residual balancing item.